Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ChatGPT Exhibits Reduced Sensitivity in Identifying Concern for Malignancy in Darker Skin Tones.

Journal of drugs in dermatology : JDD·2026
Same author

Autoimmune disease in central centrifugal cicatricial alopecia: A multi-institutional cross-sectional study.

Journal of the American Academy of Dermatology·2026
Same author

Effect of social stressors and social determinants of health (SDOH) on cancer beliefs: Analysis of a cancer center catchment area.

Journal of psychosocial oncology·2026
Same author

The United Kingdom National Programme of DCD heart transplantation: Timings, techniques, feasibility, and outcomes with abdominal normothermic regional perfusion.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis.

Cancer research·2026
Same author

Perioperative racial disparities in patients with acral lentiginous melanoma undergoing Mohs micrographic surgery: A single-institution retrospective cohort study.

Journal of the American Academy of Dermatology·2026

Related Experiment Video

Updated: May 9, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Addressing Sexual Toxicity Among Cancer Survivors: Clinicians Challenges and Potential Interventions.

Katherine Gerber1, Mehek Thapar1, Melissa Lazar2

  • 1Department of Radiation Oncology, Sidney Kimmel Medical College & Cancer Center at Thomas Jefferson University, Philadelphia, PA, USA.

The American Journal of Hospice & Palliative Care
|May 8, 2026
PubMed
Summary
This summary is machine-generated.

Oncologists often discuss sexual health with cancer patients, but lack standardized assessments and formal training. This impacts patient care and management of sexual health concerns during cancer treatment.

Keywords:
breast cancercancer survivorshiphealth communicationoncologyprostate cancersexual health

Related Experiment Videos

Last Updated: May 9, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Area of Science:

  • Oncology
  • Sexual Health
  • Healthcare Management

Background:

  • Cancer treatments can negatively impact patient sexual health.
  • Discussions about sexual health between clinicians and patients are inconsistent.
  • Effective management of sexual health concerns is crucial for cancer patient well-being.

Purpose of the Study:

  • To survey oncologists and understand their management of cancer patients' sexual health concerns.
  • To identify common sexual health issues reported by cancer patients.
  • To determine the resources oncologists utilize for sexual health support.

Main Methods:

  • An IRB-approved electronic survey was distributed to oncologists from 2017-2019.
  • The survey assessed clinicians' approaches, common patient concerns, and resource utilization.
  • Statistical analyses (Chi-square, Fisher's exact tests) examined associations between physician characteristics and responses.

Main Results:

  • 75.1% of 388 surveyed oncologists discuss sexual health, but 74.4% lack standardized assessments.
  • Most oncologists (81.9%) reported no formal training in sexual health communication.
  • Common patient concerns include sexual desire, vaginal dryness, erectile dysfunction, painful intercourse, and fertility.
  • Physicians treating prostate cancer patients were more likely to discuss sexual health and use standardized assessments than those treating female cancer patients.

Conclusions:

  • While most oncologists address sexual health, a significant gap exists in standardized assessment and formal training.
  • This lack of standardized approach and training may hinder comprehensive sexual health management for cancer patients.
  • Targeted training and development of standardized protocols are needed to improve sexual health care in oncology.